Skip to main content
Clinical Trials/CTRI/2025/10/096085
CTRI/2025/10/096085
Not yet recruiting
Phase 3 4

Comparative Study Of Surgical Outcomes Using Different Viscoelastic Agents In Topical Phacoemulsification Among Diabetic Patients With Cataracts At A Tertiary Care Centre

Datta Meghe Institute of Higher Education and Research1 site in 1 country174 target enrollmentStarted: October 20, 2025Last updated:

Overview

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Datta Meghe Institute of Higher Education and Research
Enrollment
174
Locations
1
Primary Endpoint
Postoperative corneal endothelial cell loss associated with different viscoelastic agents

Overview

Brief Summary

This is a prospective, comparative, open-label interventional study to evaluate surgical outcomes of different viscoelastic agents in topical phacoemulsification among diabetic patients with cataract at a tertiary care centre. A total of 174 patients (87 in each group) will be included. Group 1 will receive Sodium Hyaluronate Ophthalmic Solution (Hyloject) and Group 2 will receive Hypromellose Ophthalmic Solution USP (Hyprosol) during cataract surgery. The primary outcome is postoperative corneal endothelial cell loss. Secondary outcomes include visual recovery, intraocular pressure changes, and postoperative complications. The study duration will be 2 years.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
40.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Patients with senile cataract and diagnosed diabetes mellitus.
  • 2.Patients willing to give informed consent.

Exclusion Criteria

  • 1.Preoperative glaucoma or IOP more than 20 mmHg. 2.Intraoperative complications like manual dilatation of pupil, posterior capsular rent, sulcus IOL placement.
  • 3.Presence of subluxation, pseudoexfoliation, or other associated ocular/corneal pathology.
  • 4.Previous intraocular surgery in study eye.

Outcomes

Primary Outcomes

Postoperative corneal endothelial cell loss associated with different viscoelastic agents

Time Frame: Pre-Operative, Post-Operative Day 1, Day 15, and 1 Month

Secondary Outcomes

  • Visual Acuity (Both Uncorrected and Corrected Visual Acuity)(Pre-Operative, Post-Operative Day 1, Day 15, and 1 Month)
  • Intraocular Pressure (IOP) Changes(Pre-Operative, Post-Operative Day 1, Day 15, and 1 Month)
  • Postoperative Complications Related To Viscoelastic Agents(Post-Operative Day 1, Day 15, and 1 Month)

Investigators

Sponsor
Datta Meghe Institute of Higher Education and Research
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Savsani Varnil Rajeshbhai

Datta Meghe Institute of Higher Education & Research

Study Sites (1)

Loading locations...

Similar Trials